Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression
Partnering with Patients: Building Effective Communication and Support in HF Care
Partnering with Patients: Building Effective Communication and Support in HF Care
The Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
The Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
Phase 3 study results of plozasiran in patients with FCS
Phase 3 study results of plozasiran in patients with FCS
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
October 25, 2024
11:00 AM - 11:45 AM ET
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Nonsteroidal MRAs: The CKD/T1D Potential
Nonsteroidal MRAs: The CKD/T1D Potential
Diagnostic Challenges of TED: What Endocrinologists Need to Know
Diagnostic Challenges of TED: What Endocrinologists Need to Know
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
Underlying Mediators of Immune Dysregulation in TED
Underlying Mediators of Immune Dysregulation in TED
UNVEILING IgG4-RELATED DISEASE: Understanding the Systemic Features of the Great Imitator
UNVEILING IgG4-RELATED DISEASE: Understanding the Systemic Features of the Great Imitator
